findmyKOL
Clinical trialNCT03513952CompletedPhase 2Interventional

Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma

SponsorNational Cancer Institute (NCI)Enrollment47Advanced Bladder Urothelial CarcinomaAdvanced Ureter Urothelial CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Renal Pelvis Urothelial CarcinomaMetastatic Ureter Urothelial CarcinomaMetastatic Urethral Urothelial Carcinoma+18 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Kaiser Permanente-Riverside

    Riverside, California, United States

  • Moffitt Cancer Center

    Tampa, Florida, United States

  • Straub Clinic and Hospital

    Honolulu, Hawaii, United States

  • University of Hawaii Cancer Center

    Honolulu, Hawaii, United States

  • University of Chicago Comprehensive Cancer Center

    Chicago, Illinois, United States

  • East Jefferson General Hospital

    Metairie, Louisiana, United States

  • Washington University School of Medicine

    St Louis, Missouri, United States

  • Roswell Park Cancer Institute

    Buffalo, New York, United States

  • Fhcc South Lake Union

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
5 Jun 2019
Primary completion
30 Sept 2023
Completion
1 Apr 2024
Last update posted
26 Jul 2024
Registered enrollment
47
Registry id
NCT03513952
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.